Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change
12/23/2025 04:46 PM • Can-Fite BioPharma announced a 1-for-3,000 reverse stock split of its ordinary shares, approved by shareholders on November 10, 2025, effective January 5, 2026 on the Tel-Aviv Stock Exchange and NYSE American. The reverse split will also adjust the ADS ratio from 1 ADS representing 300 ordinary shares to 1 ADS representing 2 ordinary shares, equivalent to a 1-for-20 ADS split. The company's authorized shares will be reduced from 42 billion to 14 million.
CANF - Reverse stock splits of this magnitude (1-for-3,000) are typically executed by companies facing severe stock price depreciation and are often viewed negatively by investors as a sign of financial distress or failed business performance. While the split itself is neutral mechanically, the need for such an extreme consolidation indicates underlying business challenges.
Investing.com • Dave Kovaleski